TVT Registry: Favorable TAVR Outcomes in Low-risk Bicuspid Patients medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Sandoz today announced Treprostinil Injection, a generic Remodulin®, is now also available for subcutaneous ("SC") administration to treat.
email article
Progress continues to be made on new transcatheter devices for the treatment of severe mitral and tricuspid regurgitation, investigators reported.
Several valve repair and replacement technologies, designed as alternatives to surgery in high-risk patients, had promising early results presented at this year s virtual European Association of Percutaneous Cardiovascular Interventions (EuroPCR) meeting.
The larger pivotal trials for these devices are not expected to be completed for at least another few years. As such, the following all remain investigational devices in the U.S.
Tendyne in Mitral Valve Replacement
Operators reported good real-world experience with Tendyne, a tri-leaflet bioprosthetic valve from Abbott, in registry data going out to 30 days.
Patients with heart failure with reduced ejection fraction (HFrEF) did not have better health outcomes if they took sacubitril/valsartan combination therapy compared with valsartan alone, according to new data presented at the American College of Cardiology s 70th Annual Scientific Session.
TRISCEND: Tricuspid Valve Replacement System Shows Early Promise medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.